{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T02:19:19Z","timestamp":1776651559833,"version":"3.51.2"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Current guidelines for managing infections in pediatric patients with cancer do not recommend routine antibiotic prophylaxis (AP). However, several aspects of AP, including the role of diagnosis, the impact of neutropenia duration, screening for resistant bacterial colonization, and antibiotic stewardship, remain a matter of debate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To address these issues, a panel of experts from the Italian Association of Pediatric Hematology and Oncology (AIEOP) and the Italian Society of Pediatric Infectious Diseases (SITIP) conducted a Delphi consensus. A comprehensive literature review and a national survey of pediatric oncology centers identified clinically relevant topics that are not fully covered by current guidelines. Based on this, the expert panel developed and voted on 14 statements covering eight key areas: the role of diagnosis, duration of neutropenia, screening for colonization with antibiotic resistant bacteria, use of validated risk scores, implementation of antimicrobial stewardship programs, periodic monitoring of local epidemiology, choice of antibiotic for prophylaxis, and the risk of resistance following prophylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The panel reached a consensus against prophylaxis in patients receiving monoclonal antibody therapy and advised against using the duration of neutropenia alone as a criterion to initiate prophylaxis, recommending it only for severe neutropenia (&lt;\u2009500\/mm\u00b3). They also emphasized the importance of screening for multidrug resistant bacteria and implementing antimicrobial stewardship supported by specialist consultation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These recommendations provide guidance for clinicians on the selective use of AP, supporting informed decision making while ensuring appropriate treatment and reducing the emergence of multidrug resistant bacterial infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13052-025-02141-1","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:50:45Z","timestamp":1764075045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recommendations for antibacterial prophylaxis in children receiving chemotherapy: a joint initiative of SITIP and infectious disease group of AIEOP"],"prefix":"10.1186","volume":"51","author":[{"given":"Daniele","family":"Zama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4673-5876","authenticated-orcid":false,"given":"Davide","family":"Leardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Baccelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Muratore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elio","family":"Castagnola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Del Bene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maia","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Funiciello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Galaverna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Masetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Muggeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Maria","family":"Mura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Perruccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Spadea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Lo Vecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Cesaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"10","key":"2141_CR1","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.ejca.2005.03.007","volume":"41","author":"E Castagnola","year":"2005","unstructured":"Castagnola E, Caviglia I, Pistorio A, et al. Bloodstream infections and invasive mycoses in children undergoing acute leukaemia treatment: a 13-year experience at a single Italian institution. Eur J Cancer. 2005;41(10):1439\u201345.","journal-title":"Eur J Cancer"},{"key":"2141_CR2","doi-asserted-by":"crossref","unstructured":"Caselli D, Cesaro S, Fagioli F, et al. Incidence of colonization and bloodstream infection with carbapenem-resistant Enterobacteriaceae in children receiving antineoplastic chemotherapy in Italy. Volume 48. Infectious Diseases. Taylor & Francis; 2016. pp. 152\u20135. 2.","DOI":"10.3109\/23744235.2015.1087647"},{"key":"2141_CR3","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819001845","volume":"147","author":"MM Garrido","year":"2019","unstructured":"Garrido MM, Garrido RQ, Cunha TN, Ehrlich S, Martins IS. Comparison of epidemiological, clinical and microbiological characteristics of bloodstream infection in children with solid tumours and haematological malignancies. Epidemiol Infect. 2019;147:e298.","journal-title":"Epidemiol Infect"},{"issue":"6","key":"2141_CR4","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S1470-2045(20)30725-7","volume":"22","author":"T Lehrnbecher","year":"2021","unstructured":"Lehrnbecher T, Averbuch D, Castagnola E, 8th European Conference on Infections in Leukaemia, Elsevier, et al. 8th European conference on infections in leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation. Lancet Oncol. 2021;22(6):e270\u201380.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2141_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/cid\/ciz1082","volume":"71","author":"T Lehrnbecher","year":"2020","unstructured":"Lehrnbecher T, Fisher BT, Phillips B, et al. Guideline for antibacterial prophylaxis administration in pediatric cancer and hematopoietic stem cell transplantation. Clin Infect Dis. 2020;71(1):226\u201336.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2141_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","volume":"67","author":"IR Diamond","year":"2014","unstructured":"Diamond IR, Grant RC, Feldman BM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014;67(4):401\u20139.","journal-title":"J Clin Epidemiol"},{"key":"2141_CR7","doi-asserted-by":"publisher","unstructured":"Widjajanto P, Sumadiono S, Cloos J, Purwanto I, Sutaryo S, Veerman A. Randomized double blind trial of Ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia. JBM. 2013;1.\u00a0https:\/\/doi.org\/10.2147\/JBM.S3390610.2147\/JBM.S33906. PMID 23403504","DOI":"10.2147\/JBM.S3390610.2147\/JBM.S33906"},{"issue":"3","key":"2141_CR8","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1097\/INF.0b013e3182793610","volume":"32","author":"K Laoprasopwattana","year":"2013","unstructured":"Laoprasopwattana K, Khwanna T, Suwankeeree P, Sujjanunt T, Tunyapanit W, Chelae S. Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy. Pediatr Infect Disease J. 2013;32(3):e94\u20138.","journal-title":"Pediatr Infect Disease J"},{"issue":"11","key":"2141_CR9","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/cid\/cix644","volume":"65","author":"J Wolf","year":"2017","unstructured":"Wolf J, Tang L, Flynn PM, et al. Levofloxacin prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia. Clin Infect Dis. 2017;65(11):1790\u20138.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2141_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1080\/16078454.2019.1589706","volume":"24","author":"W Owattanapanich","year":"2019","unstructured":"Owattanapanich W, Chayakulkeeree M. Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis. Hematology. 2019;24(1):362\u20138.","journal-title":"Hematology"},{"issue":"1","key":"2141_CR11","first-page":"CD004386","volume":"2012","author":"A Gafter-Gvili","year":"2012","unstructured":"Gafter-Gvili A, Fraser A, Paul M, et al. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. Cochrane Database Syst Rev. 2012;2012(1):CD004386.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"2141_CR12","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1001\/jama.2018.12512","volume":"320","author":"S Alexander","year":"2018","unstructured":"Alexander S, Fisher BT, Gaur AH, et al. Effect of Levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation: a randomized clinical trial. JAMA. 2018;320(10):995\u20131004.","journal-title":"JAMA"},{"issue":"10","key":"2141_CR13","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.1002\/cam4.2395","volume":"8","author":"G Egan","year":"2019","unstructured":"Egan G, Robinson PD, Martinez JPD, et al. Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: a systematic review of randomized trials. Cancer Med. 2019;8(10):4536\u201346.","journal-title":"Cancer Med"},{"issue":"1","key":"2141_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jinf.2017.10.009","volume":"76","author":"M Mikulska","year":"2018","unstructured":"Mikulska M, Averbuch D, Tissot F, et al. Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines. J Infect. 2018;76(1):20\u201337.","journal-title":"J Infect"},{"issue":"5","key":"2141_CR15","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/INF.0b013e318245ab48","volume":"31","author":"L Sung","year":"2012","unstructured":"Sung L, Manji A, Beyene J, et al. Fluoroquinolones in children with fever and neutropenia: a systematic review of prospective trials. Pediatr Infect Dis J. 2012;31(5):431\u20135.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"2141_CR16","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/s41375-022-01556-7","volume":"36","author":"G Maschmeyer","year":"2022","unstructured":"Maschmeyer G, Bullinger L, Garcia-Vidal C, et al. Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN). Leukemia. 2022;36(5):1215\u201326.","journal-title":"Leukemia"},{"issue":"12","key":"2141_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29253","volume":"68","author":"L Lavieri","year":"2021","unstructured":"Lavieri L, Koenig C, Bodmer N, et al. Predicting fever in neutropenia with safety-relevant events in children undergoing chemotherapy for cancer: the prospective multicenter SPOG 2015 FN definition study. Pediatr Blood Cancer. 2021;68(12):e29253.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2141_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/ped.14103","volume":"62","author":"S Saito","year":"2020","unstructured":"Saito S, Yanagisawa R, Minami K, et al. Prophylactic piperacillin administration in pediatric patients with solid tumors following different intensities of chemotherapy. Pediatr Int. 2020;62(2):158\u201368.","journal-title":"Pediatr Int"},{"issue":"5","key":"2141_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26952","volume":"65","author":"ML Sulis","year":"2018","unstructured":"Sulis ML, Blonquist TM, Stevenson KE, et al. Effectiveness of antibacterial prophylaxis during induction chemotherapy in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2018;65(5):e26952.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"2141_CR20","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/cncr.28524","volume":"120","author":"T-C Yeh","year":"2014","unstructured":"Yeh T-C, Liu H-C, Hou J-Y, et al. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or Micafungin prophylaxis. Cancer. 2014;120(8):1255\u201362.","journal-title":"Cancer"},{"issue":"1","key":"2141_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1159\/000356626","volume":"132","author":"X Feng","year":"2014","unstructured":"Feng X, Ruan Y, He Y, et al. Prophylactic first-line antibiotics reduce infectious fever and shorten hospital stay during chemotherapy-induced agranulocytosis in childhood acute myeloid leukemia. Acta Haematol. 2014;132(1):112\u20137.","journal-title":"Acta Haematol"},{"issue":"6","key":"2141_CR22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/ejh.13162","volume":"101","author":"C Calitri","year":"2018","unstructured":"Calitri C, Ruberto E, Castagnola E. Antibiotic prophylaxis in neutropenic children with acute leukemia: do the presently available data really support this practice? Eur J Haematol. 2018;101(6):721\u20137.","journal-title":"Eur J Haematol"},{"issue":"7","key":"2141_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29525","volume":"69","author":"A Davis","year":"2022","unstructured":"Davis A, Stevens AM, Brackett J, et al. Levofloxacin prophylaxis for pediatric leukemia patients: longitudinal follow-up for impact on health care\u2010associated infections. Pediatr Blood Cancer. 2022;69(7):e29525.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2141_CR24","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jiac.2017.12.012","volume":"24","author":"W Tunyapanit","year":"2018","unstructured":"Tunyapanit W, Chelae S, Laoprasopwattana K. Does ciprofloxacin prophylaxis during chemotherapy induce intestinal microflora resistance to ceftazidime in children with cancer? J Infect Chemother. 2018;24(5):358\u201362.","journal-title":"J Infect Chemother"},{"issue":"3","key":"2141_CR25","first-page":"266","volume":"10","author":"E Castagnola","year":"2021","unstructured":"Castagnola E, Bagnasco F, Mesini A, et al. Antibiotic Resistant Bloodstream Infections in Pediatric Patients Receiving Chemotherapy or Hematopoietic Stem Cell Transplant: Factors Associated with Development of Resistance, Intensive Care Admission and Mortality. Antibiotics Multidisciplinary Digital Publishing Institute. 2021;10(3):266.","journal-title":"Antibiotics. Multidisciplinary Digital Publishing Institute"},{"issue":"5","key":"2141_CR26","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1089\/mdr.2021.0253","volume":"28","author":"D Averbuch","year":"2022","unstructured":"Averbuch D, Moshkovitz L, Ilan S, Abu Ahmad W, Temper V, Strahilevitz J. Bacteremia with carbapenemase-producing enterobacterales in immunocompromised patients colonized with these bacteria. Microb Drug Resist. 2022;28(5):593\u2013600.","journal-title":"Microb Drug Resist"},{"issue":"2","key":"2141_CR27","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jiph.2018.11.003","volume":"12","author":"E Castagnola","year":"2019","unstructured":"Castagnola E, Tatarelli P, Mesini A, et al. Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity. J Infect Public Health. 2019;12(2):270\u20134.","journal-title":"J Infect Public Health"},{"issue":"9","key":"2141_CR28","first-page":"7231","volume":"30","author":"MA F\u00fcller","year":"2022","unstructured":"F\u00fcller MA, Kampmeier S, W\u00fcbbolding AM, Gr\u00f6nefeld J, Kremer A, Groll AH. Prospective surveillance of colonization and disease by methicillin-resistant Staphylococcus aureus (MRSA) at a European pediatric cancer center. Support Care Cancer. 2022;30(9):7231\u20139.","journal-title":"Support Care Cancer"},{"issue":"7","key":"2141_CR29","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1097\/INF.0b013e318215a290","volume":"30","author":"P Agyeman","year":"2011","unstructured":"Agyeman P, Aebi C, Hirt A, et al. Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study. Pediatr Infect Dis J. 2011;30(7):e114\u2013119.","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"2141_CR30","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1200\/JCO.2009.25.8988","volume":"28","author":"RA Ammann","year":"2010","unstructured":"Ammann RA, Bodmer N, Hirt A, et al. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study. J Clin Oncol. 2010;28(12):2008\u201314.","journal-title":"J Clin Oncol"},{"issue":"6","key":"2141_CR31","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/bjc.2016.28","volume":"114","author":"RS Phillips","year":"2016","unstructured":"Phillips RS, Sung L, Ammann RA, et al. Predicting microbiologically defined infection in febrile neutropenic episodes in children: global individual participant data multivariable meta-analysis. Br J Cancer. 2016;114(6):623\u201330.","journal-title":"Br J Cancer"},{"issue":"1","key":"2141_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/INF.0b013e3181c3f6f0","volume":"29","author":"H Hakim","year":"2010","unstructured":"Hakim H, Flynn PM, Srivastava DK, et al. Risk prediction in pediatric cancer patients with fever and neutropenia. Pediatr Infect Dis J. 2010;29(1):53\u20139.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"2141_CR33","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/1097-0142(20010815)92:4<909::AID-CNCR1400>3.0.CO;2-H","volume":"92","author":"EP Baorto","year":"2001","unstructured":"Baorto EP, Aquino VM, Mullen CA, Buchanan GR, DeBaun MR. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia. Cancer. 2001;92(4):909\u201313.","journal-title":"Cancer"},{"issue":"27","key":"2141_CR34","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1200\/JCO.20.00591","volume":"38","author":"AJ Esbenshade","year":"2020","unstructured":"Esbenshade AJ, Zhao Z, Baird A, et al. Prospective implementation of a risk prediction model for bloodstream infection safely reduces antibiotic usage in febrile pediatric cancer patients without severe neutropenia. J Clin Oncol. 2020;38(27):3150\u201360.","journal-title":"J Clin Oncol"},{"issue":"6","key":"2141_CR35","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1177\/1060028019890886","volume":"54","author":"KE Pillinger","year":"2020","unstructured":"Pillinger KE, Bouchard J, Withers ST, et al. Inpatient antibiotic stewardship interventions in the adult oncology and hematopoietic stem cell transplant population: a review of the literature. Ann Pharmacother. 2020;54(6):594\u2013610.","journal-title":"Ann Pharmacother"},{"issue":"15","key":"2141_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154545","volume":"11","author":"E Muratore","year":"2022","unstructured":"Muratore E, Baccelli F, Leardini D, et al. Antimicrobial stewardship interventions in pediatric oncology: a systematic review. J Clin Med. 2022;11(15):4545.","journal-title":"J Clin Med"},{"issue":"2","key":"2141_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/INF.0000000000001746","volume":"37","author":"Y Horikoshi","year":"2018","unstructured":"Horikoshi Y, Kaneko T, Morikawa Y, et al. The north wind and the sun: pediatric antimicrobial stewardship program combining restrictive and persuasive approaches in Hematology-Oncology ward and hematopoietic stem cell transplant unit. Pediatr Infect Dis J. 2018;37(2):164\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"2141_CR38","doi-asserted-by":"publisher","first-page":"e2020040295","DOI":"10.1542\/peds.2020-040295","volume":"147","author":"JS Gerber","year":"2021","unstructured":"Gerber JS, Jackson MA, Tamma PD, Zaoutis TE, Committee on infectious diseases, pediatric infectious diseases society. Antibiotic stewardship in pediatrics. Pediatrics. 2021;147(1):e2020040295.","journal-title":"Pediatrics"},{"issue":"5","key":"2141_CR39","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/cid\/ciw780","volume":"64","author":"PD Tamma","year":"2017","unstructured":"Tamma PD, Avdic E, Keenan JF, et al. What is the more effective antibiotic stewardship intervention: preprescription authorization or postprescription review with feedback? Clin Infect Dis. 2017;64(5):537\u201343.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2141_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2023.102745","volume":"27","author":"MC Dufrayer","year":"2023","unstructured":"Dufrayer MC, Rechenmacher C, Meneses CF, et al. Safety of levofloxacin as an antibiotic prophylaxis in the induction phase of children newly diagnosed with acute lymphoblastic leukemia: an interim analysis of a randomized, open-label trial in Brazil. Braz J Infect Dis. 2023;27(2):102745.","journal-title":"Braz J Infect Dis"},{"issue":"12","key":"2141_CR41","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac594","volume":"9","author":"D Leardini","year":"2022","unstructured":"Leardini D, Muratore E, Abram N, et al. Effectiveness of quinolone prophylaxis in pediatric acute leukemia and hematopoietic stem cell transplantation: a systematic review and meta-analysis. Open Forum Infect Dis. 2022;9(12):ofac594.","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"2141_CR42","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/jpids\/piad041","volume":"12","author":"AM Quintero","year":"2023","unstructured":"Quintero AM, Cruz Vidal DA, Klamer BG, Ardura MI, Oyeniran SJ. Emerging resistance trends in viridans group Streptococci bloodstream infections among immunocompromised children receiving Levofloxacin prophylaxis. J Pediatr Infect Dis Soc. 2023;12(7):381\u201391.","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"4","key":"2141_CR43","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1097\/INF.0000000000000591","volume":"34","author":"S Felsenstein","year":"2015","unstructured":"Felsenstein S, Orgel E, Rushing T, Fu C, Hoffman JA. Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia. Pediatr Infect Dis J. 2015;34(4):e78-84.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"2141_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93571-4","volume":"11","author":"R Masetti","year":"2021","unstructured":"Masetti R, Biagi E, Zama D, et al. Early modifications of the gut microbiome in children with hepatic sinusoidal obstruction syndrome after hematopoietic stem cell transplantation. Sci Rep. 2021;11(1):14307.","journal-title":"Sci Rep"},{"issue":"2","key":"2141_CR45","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae707","volume":"12","author":"D Leardini","year":"2025","unstructured":"Leardini D, Gambuti G, Muratore E, et al. Levofloxacin prophylaxis in pediatric and young adult allogeneic hematopoietic stem cell transplantation recipients does not prevent infective complications and infections-related deaths. Open Forum Infect Dis. 2025;12(2):ofae707.","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"2141_CR46","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/cid\/cix646","volume":"65","author":"D Averbuch","year":"2017","unstructured":"Averbuch D, Tridello G, Hoek J, et al. Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the infectious diseases working party of the European bone marrow transplantation group. Clin Infect Dis. 2017;65(11):1819\u201328.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2141_CR47","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1038\/s41409-022-01793-5","volume":"57","author":"D Zama","year":"2022","unstructured":"Zama D, Masetti R, Baccelli F, et al. Antibiotic prophylaxis and management of infections in pediatric hematopoietic stem cell transplantation: a survey from the stem cell transplant and the infectious disease working groups of the AIEOP network. Bone Marrow Transplant. 2022;57(12):1851\u20133.","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"2141_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-04436-7","volume":"6","author":"M Fabbrini","year":"2023","unstructured":"Fabbrini M, D\u2019Amico F, Leardini D, et al. Levofloxacin prophylaxis and parenteral nutrition have a detrimental effect on intestinal microbial networks in pediatric patients undergoing HSCT. Commun Biol. 2023;6(1):36.","journal-title":"Commun Biol"},{"issue":"3","key":"2141_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031197","volume":"22","author":"R Masetti","year":"2021","unstructured":"Masetti R, Zama D, Leardini D, et al. Microbiome-derived metabolites in allogeneic hematopoietic stem cell transplantation. Int J Mol Sci. 2021;22(3):1197.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"2141_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14081932","volume":"14","author":"R Masetti","year":"2022","unstructured":"Masetti R, D\u2019Amico F, Zama D, et al. Febrile neutropenia duration is associated with the severity of gut microbiota dysbiosis in pediatric allogeneic hematopoietic stem cell transplantation recipients. Cancers (Basel). 2022;14(8):1932.","journal-title":"Cancers (Basel)"},{"issue":"16","key":"2141_CR51","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1182\/blood.2023020026","volume":"142","author":"R Masetti","year":"2023","unstructured":"Masetti R, Leardini D, Muratore E, et al. Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children. Blood. 2023;142(16):1387\u201398.","journal-title":"Blood"},{"issue":"22","key":"2141_CR52","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1182\/bloodadvances.2021005129","volume":"5","author":"R Masetti","year":"2021","unstructured":"Masetti R, Muratore E, Leardini D, et al. Gut microbiome in pediatric acute leukemia: from predisposition to cure. Blood Adv. 2021;5(22):4619\u201329.","journal-title":"Blood Adv"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02141-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-02141-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02141-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:04:17Z","timestamp":1764079457000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-025-02141-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2141"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-02141-1","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors have no conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}],"article-number":"309"}}